Thor Medical ASA

FRA:8NN (Norway)  
€ 0.08 (+0.37%) Aug 23
At Loss
P/B:
0.90
Market Cap:
€ 20.74M ($ 23.25M)
Enterprise V:
€ 17.23M ($ 19.32M)
Volume:
-
Avg Vol (2M):
9.43K
Trade In:

Business Description

Description
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.82
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.29
9-Day RSI 51.35
14-Day RSI 50.07
6-1 Month Momentum % -6.49
12-1 Month Momentum % -20.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.2
Quick Ratio 10.2
Cash Ratio 9.29

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -42.3

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % 275050
ROE % -21.26
ROA % -15.93
ROIC % -6.33
ROC (Joel Greenblatt) % -955.87
ROCE % -3.87

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 260.5
PB Ratio 0.9
EV-to-EBIT -36.52
EV-to-EBITDA -41.93
EV-to-FCF -3.17
Earnings Yield (Greenblatt) % -2.74
FCF Yield % -26.23

Financials (Next Earnings Date:2024-08-30)

FRA:8NN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Thor Medical ASA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) -0.002
EPS (TTM) (€) -0.02
Beta 1.59
Volatility % 54.09
14-Day RSI 50.07
14-Day ATR (€) 0.002535
20-Day SMA (€) 0.08057
12-1 Month Momentum % -20.91
52-Week Range (€) 0.0641 - 0.136
Shares Outstanding (Mil) 234.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Thor Medical ASA Filings

Filing Date Document Date Form
No Filing Data

Thor Medical ASA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Thor Medical ASA Frequently Asked Questions

What is Thor Medical ASA(FRA:8NN)'s stock price today?
The current price of FRA:8NN is €0.08. The 52 week high of FRA:8NN is €0.14 and 52 week low is €0.06.
When is next earnings date of Thor Medical ASA(FRA:8NN)?
The next earnings date of Thor Medical ASA(FRA:8NN) is 2024-08-30.
Does Thor Medical ASA(FRA:8NN) pay dividends? If so, how much?
Thor Medical ASA(FRA:8NN) does not pay dividend.

Press Release

Subject Date
No Press Release